Price Target Increase#
TD Cowen has raised its price target on IDEX Corp shares from $250 to $260, while keeping a Buy rating. Currently, IDEX stock is trading at $217.34, reflecting a 27% increase over the past six months.
Strong Order Growth#
The firm highlighted that IDEX has achieved its second consecutive quarter of double-digit order growth. This trend helps to mitigate risks associated with the company's guidance for the second half of the year, which some analysts view as conservative despite a recent increase.
Focus on Growth Markets#
TD Cowen noted that IDEX's management is shifting towards growth, showing positive results in key markets such as space, data centers, and semiconductors. These sectors are of particular interest to investors.
Future Potential in Life Sciences#
The life sciences segment, which accounts for 15% of IDEX's sales, is seen as a future contributor and a potential driver for growth by 2027. This positions IDEX favorably for long-term success.
Recent Financial Performance#
In its latest financial report for the first quarter of 2026, IDEX surpassed analyst expectations with an earnings per share (EPS) of $2.00, exceeding the forecast of $1.77. The company's revenue also outperformed projections, reaching $887 million compared to the anticipated $845.75 million, marking a 5% organic increase across all business segments. Additionally, the adjusted EBITDA margin improved to 26.0%, surpassing the consensus estimate of 24.8%.
Analyst Reactions#
In response to IDEX's strong performance, Mizuho raised its price target for the company from $170 to $210, while maintaining a Neutral rating, citing robust order growth as a key factor in their decision.